{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:25:19Z","timestamp":1794493519571,"version":"4.9.1"},"reference-count":26,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Eskisehir Osmangazi University Research","award":["TSA-2023-2599"],"award-info":[{"award-number":["TSA-2023-2599"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Emerging evidence suggests that the genitourinary microbiota may influence the development and progression of urological malignancies, including bladder cancer. This study aimed to characterize the urinary microbiota at diagnosis in patients with bladder cancer and compare findings with healthy controls. Materials and Methods: Urine samples were collected from 30 patients with treatment-na\u00efve bladder cancer and 20 age- and sex-matched healthy individuals. Microbiota composition was analyzed using 16S rRNA sequencing, and subgroup comparisons were made between muscle-invasive bladder cancer (MIBC) and non-muscle-invasive bladder cancer (NMIBC). Differentially abundant taxa were identified using linear discriminant analysis effect size (LEfSe) with an LDA threshold &gt; 2 and p &lt; 0.05. Results: No significant differences were observed in alpha or beta diversity between patients and controls or between MIBC and NMIBC. At the phylum level, Firmicutes was dominant in both groups but relatively more abundant in bladder cancer cases. Enterococcus was the most abundant genus in the cancer group (35.0%) and especially in MIBC (58.0%), while Lactobacillus was more prevalent in healthy controls (19.8% vs. 9.5%). At the species level, Veillonella dispar was notably enriched in MIBC cases (70.9%) compared to NMIBC (3.9%). LEfSe analysis revealed significant enrichment of Ralstonia, Microbacterium, and Facklamia in patients with bladder cancer, while Parvimonas, Sneathia, Gemella, and Acinetobacter guillouiae were more abundant in controls. Conclusions: These findings highlight preliminary microbiota differences associated with bladder cancer and tumor invasiveness; however, the results are exploratory and larger studies are required to evaluate their diagnostic or clinical relevance.<\/jats:p>","DOI":"10.3390\/medicina61122240","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:45:07Z","timestamp":1766065507000},"page":"2240","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urinary Microbiota Composition in Treatment-Na\u00efve Bladder Cancer: A Case\u2013Control Study with Tumor Invasiveness Stratification"],"prefix":"10.3390","volume":"61","author":[{"given":"Ahmet","family":"Kayer","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-486X","authenticated-orcid":false,"given":"Ata","family":"\u00d6zen","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0339-0134","authenticated-orcid":false,"given":"Ener \u00c7a\u011fr\u0131","family":"Dinleyici","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_4","first-page":"100661","article-title":"Non-urothelial and urothelial variants of bladder cancer","volume":"33","author":"Yu","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Grabe-Heyne, K., Henne, C., Mariappan, P., Geiges, G., P\u00f6hlmann, J., and Pollock, R.F. (2023). Intermediate and high-risk non-muscle-invasive bladder cancer: An overview of epidemiology, burden, and unmet needs. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1170124"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urolonc.2021.05.015","article-title":"Non-muscle-invasive bladder cancer: An overview of potential new treatment options","volume":"39","author":"Shore","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41585-024-00963-y","article-title":"Metastasis development in non-muscle-invasive bladder cancer","volume":"22","author":"Leyderman","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/uro2.11","article-title":"Clinical practice guideline on bladder cancer (Part I)","volume":"1","author":"Dong","year":"2023","journal-title":"UroPrecision"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","article-title":"What defines a healthy gut microbiome?","volume":"73","author":"Cani","year":"2024","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41585-018-0104-z","article-title":"Community profiling of the urinary microbiota: Considerations for low-biomass samples","volume":"15","author":"Karstens","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kustrimovic, N., Bilato, G., Mortara, L., and Baci, D. (2024). The urinary microbiome in health and disease: Relevance for bladder cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031732"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Heidar, N.A., Bhat, T.A., Shabir, U., and Hussein, A.A. (2023). The urinary microbiome and bladder cancer. Life, 13.","DOI":"10.3390\/life13030812"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pallares-Mendez, R., Brassetti, A., Bove, A.M., and Simone, G. (2024). Insights into the interplay between the urinary microbiome and bladder cancer: A comprehensive review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164927"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gwon, Y.N., Park, J.J., Lee, K.S., Lee, K.H., Kim, T.H., and Kim, J.H. (2022). Microbiome in bladder cancer: A systematic review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13010084"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Zitvogel","year":"2021","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4824909","DOI":"10.1155\/2019\/4824909","article-title":"Common core bacterial biomarkers of bladder cancer based on multiple datasets","volume":"2019","author":"Mai","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, P., Zhang, G., Zhao, J., Chen, J., Chen, Y., Huang, W., Zhong, J., and Zeng, J. (2018). Profiling the urinary microbiota in male patients with bladder cancer in China. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00167"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota: A potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.urolonc.2020.04.014","article-title":"Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution feasibility study","volume":"38","author":"Chipollini","year":"2020","journal-title":"Urol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Chow","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sheng, Z., Xu, J., Wang, M., Xu, X., Zhu, J., Zeng, S., Xu, C., and Zhang, Z. (2025). The role of urinary microbiota in primary and recurrent bladder cancer: Insights from a propensity score matching study. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13817-6"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: Examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Parra-Grande, M., Or\u00e9-Arce, M., Mart\u00ednez-Priego, L., D\u2019Auria, G., Rossell\u00f3-Mora, R., Lillo, M., Sempere, A., Lumbreras, B., and S\u00e1nchez-Hell\u00edn, V. (2022). Profiling the bladder microbiota in patients with bladder cancer. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.718776"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sun, J.X., Xia, Q.D., Zhong, X.Y., Liu, Z., and Wang, S.G. (2023). The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1182322"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/JU.0000000000001336","article-title":"The microbiome of catheter-collected urine in males with bladder cancer according to disease stage","volume":"205","author":"Oresta","year":"2021","journal-title":"J. Urol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2240\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:09:34Z","timestamp":1766066974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["medicina61122240"],"URL":"https:\/\/doi.org\/10.3390\/medicina61122240","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}